KnowGovUnderstand. Power. Act.
HR10094HealthIn Committee

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026

Introduced
Aug 13, 2026
4 days ago
Last Action
Aug 13, 2026
4 days ago
1Bill Sponsor
7Bill Co-Sponsors
0Traction
1Months in Committee

Bill Summary

Requires drug companies to sell prescription drugs funded by taxpayer money at a lower price. Limits the price of these drugs to the cost of production plus a reasonable profit.

Read Full Summary

Sponsored By

Val T. Hoyle
Democrat · Oregon · House

Support By Party

View details →
0%Bipartisan
Republican0
Democratic1
Bipartisan0 · 0%

Bill Journey

  1. Aug 13, 2026
    Rep. Val T. Hoyle (D-OR)
  2. Committee on Energy and Commerce
  3. Aug 13, 2026You Are Here

    The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.

  4. TBD

    The full chamber debates the bill, may amend it, and votes on whether to pass it.

  5. TBD

    If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.

  6. TBD

    If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

This bill affects people who use taxpayer-funded prescription drugs, potentially lowering their out-of-pocket costs. It also impacts drug companies that receive taxpayer funding, as they would be required to sell their drugs at a lower price.

Cosponsors (7)

The member list hasn't been captured yet — see the full list on congress.gov.